Aldose Reductase: A Key Player in Myocardial Ischemic Injury

Exercise and Sport Sciences Reviews

Volumn 32, Issue 1, 2004, Pages 19-23

  Kaneko, Michiyo ^a   Ramasamy, Ravichandran ^a  

^a Columbia University ^*  (United States)

Author keywords

Adenosine triphosphate; Aldose reductase; Energy metabolism; Ischemic injury; Myocardial ischemia; Polyol pathway

Indexed keywords

6 PHOSPHOFRUCTOKINASE; ADENOSINE TRIPHOSPHATE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; GLUCOSE 6 PHOSPHATE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; HEXOKINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; ZOPOLRESTAT;

CLINICAL TRIAL; DIABETES MELLITUS; DRUG TARGETING; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; GENETIC POLYMORPHISM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGENOLYSIS; GLYCOLYSIS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART MUSCLE REPERFUSION; HUMAN; OXIDATION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW;

ALDEHYDE REDUCTASE; ENZYME INHIBITORS; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; REPERFUSION INJURY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 0347122975     PISSN: 00916331     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003677-200401000-00005     Document Type: Review

References (15)

1. Camici, P., E. Ferrannini, and L. H. Opie. Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog. Cardiovasc. Dis. 32:217-238, 1989.
2. Diaz, R., E. A. Paolasso, L. S. Piegas, C. D. Tajer, M. G. Moreno, R. Corvalan, J. E. Isea, and G. Romero. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latino-america) Collaborative Group. Circulation 98:2227-2234, 1998.
3. Hwang, Y. C., S. Sato, J. Y. Tsai, S. Bakr, S. D. Yan, P. J. Oates, and R. Ramasamy. Aldose reductase activation is a key component of myocardial response to ischemia. FASEB J. 16:243-245, 2002.
4. Oates, P. J. Polyol pathway and diabetic peripheral neuropathy. In: Tomlinson, D. R., ed. International Review of Neurobiology. London: Academic Press, 2002;325-392.
5. Opie, L. H., M. Tansey, and B. M. Kennelly. Proposed metabolic vicious circle in patients with large myocardial infarcts and high plasma-free-fatty-acid concentrations. Lancet 2:890-892, 1977.
6. Ramasamy, R., and S. R. Bergmann. Adjunctive protection of ischemic myocardium by modification of metabolism. In: DeBono, D. P., and B. E. Sobel, eds. Challenges in Acute Coronary Syndromes. Oxford: Blackwell Science, 2001;253-268.
7. Ramasamy, R., Y. C. Hwang, J. Whang, and S. R. Bergmann. Protection of ischemic hearts by high glucose is mediated, in part, by GLUT-4. Am. J. Physiol. 281:H290-H297, 2001.
8. Ramasamy, R., H. Liu, P. J. Oates, S. Schaefer. Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat. Cardiovasc. Res. 42:130-139, 1999.
9. Ramasamy, R., and P. J. Oates. Aldose reductase and vascular stress. In: Stern, D. M., and S. P. Marso, eds. Diabetes and Cardiovascular Disease. Philadelphia: Lippincott Williams & Wilkins, 2003;55-74.
10. Ramasamy, R., P. J. Oates, and S. Schaefer. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes 46:292-300, 1997.
11. Stanley, W. C., G. D. Lopaschuk, J. L. Hall, and J. G. McCormack. Regulation of myocardial carbohydrate metabolism under normal and ischemic conditions. Potential for pharmacological interventions. Cardiovasc. Res. 33:243-257, 1997.
12. Taegtmeyer, H., L. M. King, and B. E. Jones. Energy substrate metabolism, myocardial ischemia, and targets for pharmacotherapy. Am. J. Cardiol. 82:54K-60K, 1998.
13. Tracey, W. R., W. P. Magee, C. A. Ellery, J. T. MacAndrew, A. H. Smith, D. R. Knight, and P. J. Oates. Aldose reductase inhibition alone or combined with an adenosine A(3) agonist reduces ischemic myocardial injury. Am. J. Physiol. 279:H1447-H1452, 2000.
14. Trueblood, N. A., and R. Ramasamy. Aldose reductase inhibition improves altered glucose metabolism of isolated diabetic rat hearts. Am. J. Physiol. 275:H75-H83, 1998.
15. Young, L. H., Y. Renfu, R. Russell, X. Hu, M. Caplan, J. Ren, G. I. Shulman, and A. J. Sinusas. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 95:415-422, 1997.